tetrafluoroaluminate has been researched along with prostaglandin d2 in 1 studies
| Studies (tetrafluoroaluminate) | Trials (tetrafluoroaluminate) | Recent Studies (post-2010) (tetrafluoroaluminate) | Studies (prostaglandin d2) | Trials (prostaglandin d2) | Recent Studies (post-2010) (prostaglandin d2) |
|---|---|---|---|---|---|
| 170 | 1 | 10 | 3,454 | 78 | 751 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alpert, J; Colodzin, R; Koutsos, M; McHale, NL; Mooney, JJ; Samson, JA; Schildkraut, JJ | 1 |
1 trial(s) available for tetrafluoroaluminate and prostaglandin d2
| Article | Year |
|---|---|
Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection).
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adult; Aluminum Compounds; Blood Platelets; Depressive Disorder; Dinoprostone; Female; Fluorides; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Prostaglandin D2; Psychiatric Status Rating Scales; Signal Transduction | 1998 |